Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

Recruiting Observational Study
Urothelial Cancer Cancer Bladder Neoplasms Urinary Bladder Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Lahey Clinic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up) * Control Group: No known evidence of bladder cancer-one urine sample * \> than 18 years of age Exclusion Criteria: * \< than…
Contacts

Kimberly Rieger-Christ, PhD

781-744-2969

Kimberly.R.Christ@lahey.org

CONTACT

Linda M. Topjian

781-744-8711

Linda.M.Topjian@Lahey.org

CONTACT